CHSPR Seminar | Big Data Down Under: Implications for Pharmaceutical Policy Research

Sallie Pearson, Centre for Big Data Research in Health at the University of New South Wales

Tuesday, June 20, 2017
1:00–2:00 pm
Room B104, 2206 East Mall
School of Population and Public Health
University of British Columbia

There is a growing recognition of the importance of observational studies using big data to examine the use and impact of prescribed medicines in routine clinical care. Australia is replete with world-class registries, bio-repositories and whole-of-population administrative data to advance this agenda. In her presentation, Sallie will discuss Australia’s capacity to harness big data to examine the ever-changing prescription medicine marketplace, highlight the challenges in undertaking high quality pharmacoepidemiological research in Australia and share some case studies of research supporting local pharmaceutical policy decision making.

Sallie Pearson is Professor and Head of the Medicines Policy Research Unit, Centre for Big Data Research in Health, at the University of New South Wales. Sallie is a health service researcher and behavioural scientist with almost 20 years of experience in quality use of medicines research. In the last decade her research has had a strong focus on the post-market surveillance of prescribed medicines using population-based, linked, routinely collected data.

A light lunch is included in this seminar. Please contact Joyce Huang ( to RSVP for lunch by Friday, June 16th. You may also join remotely via GoToMeeting: Please let Joyce know if you would like to join this way.